Plain-English translation of NCT07304401 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is testing a device called closed-loop spinal cord stimulation (CL-SCS), which is implanted near your spinal cord to help relieve chronic nerve pain caused by chemotherapy. Unlike older stimulator versions, this system automatically adjusts its electrical signals in real time based on how your body responds, potentially offering better pain relief. The trial will follow 20 patients to see how well the Evoke SCS System works for chemotherapy-related nerve damage.
Nerve pain from chemotherapy affects up to 40% of cancer patients and is often difficult to treat with medications alone. This trial exists to test whether a newer, smarter version of spinal cord stimulation—one that adjusts itself automatically—works better than traditional approaches for this type of pain.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will undergo a surgical procedure to have the Evoke SCS System implanted near your spinal cord—this is a standard procedure offered in the Netherlands for chemotherapy-related nerve pain. Once implanted, the device will automatically adjust its electrical signals based on how your body responds. Throughout the study, you will visit the hospital for check-ups and complete questionnaires about your pain levels and quality of life to help researchers understand how well the treatment works.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
Netherlands